Delivery Order SPE2DB22D3004-SPE2DB24FPH17
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide RABAVERT Rabies Vaccine with diluents. The $9,651.50 award has a performance period through March 5, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) with DLA valued up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,930.30 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide RABAVERT rabies vaccine with diluents. The delivery order has a completion date of March 7, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,651.50 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide RABAVERT rabies vaccine with diluents. This delivery order does not have a set-aside designation and is scheduled for completion by February 8, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is issued under an indefinite delivery contract (IDC) they hold with DLA. The IDC has...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $9,651.50 to provide RABAVERT rabies vaccine with diluents. This award is part of Amerisourcebergen's broader contract vehicle with DLA, an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order valued at $1,302.76 by the Defense Logistics Agency (DLA) Troop Support Medical to provide RABAVERT rabies vaccine with diluents. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp to serve as the primary contract vehicle for delivering pharmaceutical products and medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide $5,359.12 worth of RABAVERT rabies vaccine with diluents. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 2025, to deliver pharmaceutical products and medical supplies to support military treatment programs and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,246.72 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide RabAvert rabies vaccine with diluents. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $15,442.40 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,176,731 units of the RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $1,930.30 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order by the Defense Logistics Agency (DLA) to provide RABAVERT Rabies Vaccine with Diluents. The $1,930.30 contract has a completion date of February 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, notably the...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPH17Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,123.33 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide RABAVERT rabies vaccines with diluents. This award has a completion date of February 14, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Firm fixed price task orders issued under this IDC enable Amerisourcebergen to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/13/24 |